The need for emergency treatment of transient ischemic attack and minor stroke

Expert Review of Neurotherapeutics

Volumn 5, Issue 2, 2005, Pages 203-210

  Giles, Matthew F ^a   Rothwell, Peter M ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Emergency treatment; Minor stroke; Transient ischemic stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL FEATURE; DIABETES MELLITUS; DIFFUSION WEIGHTED IMAGING; EMERGENCY TREATMENT; HIGH RISK PATIENT; HUMAN; MUSCLE WEAKNESS; PRACTICE GUIDELINE; REVIEW; SECONDARY PREVENTION; SPEECH DISORDER; STROKE; TRANSIENT ISCHEMIC ATTACK;

CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC IMAGING; DISABILITY EVALUATION; EMERGENCY TREATMENT; ENDARTERECTOMY, CAROTID; EXPERT TESTIMONY; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PLATELET AGGREGATION INHIBITORS; RISK;

EID: 15944395776     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.5.2.203     Document Type: Review

References (54)

1. Rothwell PM, Coull AJ, Giles MF et al. for the Oxford Vascular Study. Change in stroke incidence, mortality, case fatality, severity and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363, 1925-1933 (2004). High-quality population-based stroke and transient ischemic attack (TIA) incidence study showing an increasing age-specific rate in the elderly.
2. Stroke Care: Reducing the Burden of Disease. The Stroke Association. London, UK (1998).
3. Menken M, Munsat TL, Toole JF. The Global Burden of Disease Study. Implications for neurology. Arch. Neurol. 57, 418-420 (2000).
4. Murray CJL, Lopez AD. The global burden of disease. A comprehensive assessment of mortality and disability from disease, injuries and risk factors projected to 2020. Harvard University Press, MA, USA (1996).
5. Hankey GJ. Impact of treatment of people with transient ischaemic attack on stroke incidence and public health. Cerebrovasc. Dis. 6(Suppl), 26-33 (1996).
6. The Intercollegiate Working Party for Stroke. National Clinical Guidelines for Stroke. RCPL, London, UK (2004).
7. Wolf PA, Clagett GP, Easton JD et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 30, 1991-1994 (1999).
8. The Intercollegiate Working Party for Stroke. National Clinical Guidelines for Stroke. RCPL, London, UK (2002).
9. Johnston SC, Smith WS. Practice variability in management of transient ischemic attacks. Eur. Neurol. 42, 105-108 (1999).
10. Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospital-referred transient ischaemic attacks. J. Neurol. Neurosurg. Psychiatry 54, 793-802 (1991).
11. Gubitz G, Phillips S, Dwyer V. What is the cost of admitting patients with transient ischemic attacks to hospital? Cerebrovasc. Dis. 9, 210-214 (1999).
12. Warlow CP, Dennis MS, van Gijn J, Sandercock PAG, Bamford JM, Wardlaw JM. Preventing recurrent stroke and other serious vascular events. In: Stroke: a Practical Guide to Management. Blackwell Science Ltd, Oxford, UK (2001).
13. Gubitz G, Sandercock P. Prevention of ischaemic stroke. Br. Med. J. 321, 1455-1459 (2000).
14. Rothwell PM. Incidence, risk factors and prognosis of stroke and transient ischaemic attack: the need for high-quality large-scale epidemiological studies. Cerebrovasc. Dis. 16(Suppl. 3), 2-10 (2003).
15. Lovett J, Dennis M, Sandercock PAG, Bamford J, Warlow CP, Rothwell PM. The very early risk of stroke following a TIA. Stroke 34, e138-e40 (2003). Analysis of Oxfordshire Community Stroke Project data illustrating how different methods of analysis provide different estimates of stroke recurrence after TIA.
16. Coull A, Lovett JK, Rothwell PM, on behalf of the Oxford Vascular Study. Early risk of stroke after a TIA or minor stroke in a population-based incidence study. Br. Med. J. 328, 326-328 (2004). Population-based estimates of risk of recurrent stroke following minor stroke or TIA at 7 days, 1 month and 3 months.
17. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 284, 2901-2906 (2000). Cohort study of people within a health maintenance organization estimating risk of stroke following emergency department attendance with physician-diagnosed TIA.
18. Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack. A population-based study. Neurology 62, 2015-2020 (2004).
19. Lovett JK, Coull A, Rothwell PM, on behalf of the Oxford Vascular Study. Early risk of recurrent stroke by aetiological subtype: implications for stroke prevention. Neurology 62, 569-574 (2004). Meta-analysis of four population-based stroke and TIA incidence studies providing estimates of stroke recurrence according to etiological subtype.
20. Adams HP Jr, Bendixen BH, Rappelle LJ et al. Classification of sub-type of acute ischaemic stroke. Definitions for use in multicenter clinical trials. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 21, 35-41 (2001).
21. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoefer B, Heuschmann PU. Epidemiology of ischemic stroke of subtypes according to TOAST criteria: incidence, recurrence and long term survival in ischemic stroke subtypes: a population based study. Stroke 32, 2735-2740 (1993).
22. Petty GW, Brown R-DJ, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO, Ischaemic stroke subtypes: a population based study of functional outcome, survival and recurrence. Stroke 31, 1062-1068 (2000).
23. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project - 1981-1986. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry 53, 16-22 (1990).
24. Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJM. Early risk of stroke after transient ischemic attack in patients with internal carotid artery disease. CMAJ 170, 1105-1109 (2004).
25. Gladstone DJ, Kapral MK, Fang J, Laupacis A, Tu JV. Management and outcomes of transient ischaemic attacks in Ontario. CMAJ 170(7), 1099-1104 (1992).
26. Hankey GJ, Slattery JM, Warlow CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J. Neurol. Neurosurg. Psychiatry 55, 640-652 (2004).
27. Dutch TIA Study Group. Predictors of major vascular events in patients with a transient ischaemic attack or non-disabling stroke. Stroke 24, 527-531 (2001).
28. Benavente O, Eliasziw M, Streifler JY, Fox AJ, Barnett HJ, Meldrum H for the NASCET Collaborators. Prognosis after transient monocular blindness associated with carotid artery stenosis. N. Engl. J. Med. 345, 1084-1090 (1993).
29. Kernan WN, Viscoli CM, Brass LM et al. The Stroke Prognosis Instrument II (SPI II): a clinical prediction instrument for patients with transient ischaemia and non-disabling ischaemic stroke. Stroke 31, 456-462 (2003).
30. Flossman E, Rothwell PM. Prognosis of vertebrobasilar TIA and minor ischaemic stroke. Brain 126, 1940-1954 (2000).
31. Armstrong PW, Fu Y, Chang W-C et al. for GUSTO-IIb Investigators. Acute coronary syndromes in GUSTO-IIb Trial: prognostic insights and impact of recurrent ischaemia. Circulation 98, 1860-1868 (1998).
32. van Swieten JC, Kappelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J. Hypodensity of cerebral white matter in patients with transient ischaemic attack or minor stroke: influence on the rate of subsequent stroke: Dutch TIA Study Group. Ann. Neurol. 32, 177-183 (1992).
33. Evans GW, Howard G, Murros KE, Rose LA, Toole JF. Cerebral infarction verified by cranial computed tomography and prognosis for survival following transient ischemic attack. Stroke 22, 431-436 (1991).
34. The Dutch TIA Trial Study Group. Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke. Stroke 24, 527-531 (1993).
35. Davalos A, Matias-Guiu J, Torrent O, Vilaseca J, Codina A. Computed tomography in reversible ischaemic attacks: clinical and prognostic correlations in a prospective study. J. Neurol. 235, 155-158 (1988).
36. Dennis M, Bamford J, Sandercock P, Molyneux A, Warlow C. Computed tomography in patients with transient ischaemic attacks: when is a transient ischaemic attack not a transient ischaemic attack but a stroke? J. Neurol. 237, 257-261 (1990).
37. Eliasziw M, Streifler JY, Spence JD, Fox AJ, Hachinski VC, Barnett HJ. Prognosis for patients following a transient ischemic attack with and without a cerebral infarction on brain CT: North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Neurology 45, 428-431 (1995).
38. Douglas CD, Johnston CM, Elkins J, Sidney S, Gress DR, Johnston SC. Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke 34, 2894-2899 (1998).
39. Wen HM, Lam WWM, Rainer T et al. Multiple acute cerebral infarcts on diffusion-weighted imaging and risk of recurrent stroke. Neurology 63, 1317-1319 (2004).
40. Purroy F, Montaner J, Rovira A, Delgado P, Quintana M, Alvarez-Sabin J. Higher risk of further vascular events among transient ischaemic attack patients with diffusion-weighted imaging acute lesions. Stroke 35, 2313-2319 (2004).
41. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 349, 1641-1649 (1997).
42. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both or neither among 19 435 patients with acute ischaemic stroke. Lancet 349, 1569-1581 (1997).
43. Hankey GJ. Ongoing and planned trials of antiplatelet therapy in acute and long term management of patients with ischaemic brain syndromes: setting a new standard of care. Cerebrovasc. Dis. 17(Suppl. 3), 11-16 (2004).
44. Diener HC, Bogousslavsky J, Brass LM et al. on behalf of the MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomised double-blind, placebo-controlled trial. Lancet 364, 331-337 (2004).
45. Rothwell PM, Gutnikov SA, Eliasziw M et al. patient data from randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361, 107-116 (2003).
46. Bond R, Rerkasem K, Rothwell PM. A systematic review of the risks of carotid endarterectomy in relation to the clinical indication and the timing of surgery. Stroke 34, 2290-2301 (2003).
47. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM, for the Carotid Endarterectomy Trialists' Collaboration. Effect of endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and the timing of surgery. Lancet 363, 915-924 (2003).
48. Bond R, Rerkasem K, Rothwell PM. A systematic review of the risks of carotid endarterectomy in relation to the clinical indication and the timing of surgery. Stroke 34, 2290-2301 (2003).
49. Schwartz GG, Olsson AG, Ezekowitz MD et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: a randomized controlled trial. JAMA 285, 1711-1718 (2001).
50. Heart Protection Study Collaborative Group. Effects of cholesterol lowering with Simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high risk conditions. Lancet 363, 757-767 (2004).
51. Gubitz G, Sandercock P, Counsell C. Anticoagulants for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2, CD000024.pub2 (2004).
52. Johnston SC, Fayad PB, Gorelick PB et al. Prevalence and knowledge of transient ischemic attack among US adults. Neurology 60, 1429-1434 (2004).
53. Castaldo JE, Nelson JJ, Reed JF, Longenecker JE, Toole JF. The delay in reporting symptoms of carotid artery stenosis in an at-risk population. The Asymptomatic Carotid Atherosclerosis Study experience: a statement of concern regarding watchful waiting. Arch. Neurol. 54, 1267-1271 (1997).
54. Giles MF, Rothwell PM. Determinants of delay in seeking medical attention after a TIA or minor stroke. Cerebrovasc. Dis. 17(Suppl. 5), 6 (2003). Perceptions data collected from TIA and minor stroke patients attending dedicated clinics in the UK showing that less than half correctly recognize the cause of their symptoms and act as in an emergency.